Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

320 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Drug-induced thrombotic microangiopathy: incidence, prevention and management.
Pisoni R, Ruggenenti P, Remuzzi G. Pisoni R, et al. Among authors: ruggenenti p. Drug Saf. 2001;24(7):491-501. doi: 10.2165/00002018-200124070-00002. Drug Saf. 2001. PMID: 11444722 Review.
ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
Ruggenenti P, Mosconi L, Vendramin G, Moriggi M, Remuzzi A, Sangalli F, Remuzzi G. Ruggenenti P, et al. Am J Kidney Dis. 2000 Mar;35(3):381-91. doi: 10.1016/s0272-6386(00)70190-9. Am J Kidney Dis. 2000. PMID: 10692263 Clinical Trial.
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria.
Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G. Ruggenenti P, et al. Lancet. 1999 Jul 31;354(9176):359-64. doi: 10.1016/S0140-6736(98)10363-X. Lancet. 1999. PMID: 10437863 Clinical Trial.
Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura.
Ruggenenti P, Noris M, Remuzzi G. Ruggenenti P, et al. Kidney Int. 2001 Sep;60(3):831-46. doi: 10.1046/j.1523-1755.2001.060003831.x. Kidney Int. 2001. PMID: 11532079 Review.
Increased fragmentation of von Willebrand factor, due to abnormal cleavage of the subunit, parallels disease activity in recurrent hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and discloses predisposition in families. The Italian Registry of Familial and Recurrent HUS/TTP.
Galbusera M, Noris M, Rossi C, Orisio S, Caprioli J, Ruggeri ZM, Amadei B, Ruggenenti P, Vasile B, Casari G, Remuzzi G. Galbusera M, et al. Among authors: ruggenenti p. Blood. 1999 Jul 15;94(2):610-20. Blood. 1999. PMID: 10397728
Unrecognized pattern of von Willebrand factor abnormalities in hemolytic uremic syndrome and thrombotic thrombocytopenic purpura.
Galbusera M, Benigni A, Paris S, Ruggenenti P, Zoja C, Rossi C, Remuzzi G. Galbusera M, et al. Among authors: ruggenenti p. J Am Soc Nephrol. 1999 Jun;10(6):1234-41. J Am Soc Nephrol. 1999. PMID: 10361861 Clinical Trial.
Hypocomplementemia discloses genetic predisposition to hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: role of factor H abnormalities. Italian Registry of Familial and Recurrent Hemolytic Uremic Syndrome/Thrombotic Thrombocytopenic Purpura.
Noris M, Ruggenenti P, Perna A, Orisio S, Caprioli J, Skerka C, Vasile B, Zipfel PF, Remuzzi G. Noris M, et al. Among authors: ruggenenti p. J Am Soc Nephrol. 1999 Feb;10(2):281-93. J Am Soc Nephrol. 1999. PMID: 10215327
Pathophysiology and management of thrombotic microangiopathies.
Ruggenenti P, Remuzzi G. Ruggenenti P, et al. J Nephrol. 1998 Nov-Dec;11(6):300-10. J Nephrol. 1998. PMID: 10048496 Review.
alpha 1-Antitrypsin therapy in a case of thrombotic thrombocytopenic purpura.
Galbusera M, Ruggenenti P, Noris M, Burnouf-Radosevich M, Benigni A, Mannucci PM, Remuzzi G. Galbusera M, et al. Among authors: ruggenenti p. Lancet. 1995 Jan 28;345(8944):224-5. doi: 10.1016/s0140-6736(95)90224-4. Lancet. 1995. PMID: 7823715
The hemolytic uremic syndrome.
Remuzzi G, Ruggenenti P. Remuzzi G, et al. Among authors: ruggenenti p. Kidney Int. 1995 Jul;48(1):2-19. doi: 10.1038/ki.1995.261. Kidney Int. 1995. PMID: 7564079 Review. No abstract available.
320 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback